![[Featured Stock] CJ CheilJedang Subsidiary CJ Bioscience Hits Upper Limit for Second Day](https://cphoto.asiae.co.kr/listimglink/1/2024072208164559128_1721603806.jpg)
CJ CheilJedang's subsidiary CJ Bioscience has recorded the upper price limit for two consecutive days.
At 9:41 AM on the 20th, CJ Bioscience was trading at 14,780 KRW, up 29.99% from the previous day.
The parent company, CJ CheilJedang, is reportedly contacting acquisition candidates by appointing Morgan Stanley as the lead underwriter to sell its bio business division.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
!["Sold Out Even at 10,000 Won Each... Even An Seongjae Struggles with the 'Dujjonku' Craze [Jumoney Talk]"](https://cwcontent.asiae.co.kr/asiaresize/183/2026010210110176469_1767316261.jpg)
![15-Year Veteran Field Mechanic Becomes AI Talent... Korean Air's Experiment [AI Era, Jobs Are Changing]](https://cwcontent.asiae.co.kr/asiaresize/319/2025121111232252273_1765419802.jpg)
